MediWound (MDWD) Research & Development (2013 - 2026)

MediWound has reported Research & Development for 14 years, with the latest figure at $5.9 million in Q2 2026.

• On a quarterly basis, Research & Development rose 69.03% year-over-year to $5.9 million in Q2 2026; TTM through Jun 2026 was $19.0 million, a 60.08% increase from a year earlier, with the FY2025 full-year figure at $14.3 million, up 61.3% from the prior year.
• Research & Development was $5.9 million for Q2 2026 at MediWound, up from $5.2 million in the prior quarter.
• The five-year high for Research & Development was $5.9 million in Q2 2026, with the low at $1.5 million in Q1 2024.
• Average Research & Development over 5 years is $2.9 million, with a median of $2.6 million recorded in 2022.
• The sharpest annual moves came in 2023 and 2025: Research & Development sank 46.83% in 2023, then jumped 96.33% in 2025.
• Over 5 years, Research & Development stood at $2.7 million in 2022, then slumped by 33.01% to $1.8 million in 2023, then jumped by 65.15% to $3.0 million in 2024, then surged by 49.97% to $4.5 million in 2025, then jumped by 31.78% to $5.9 million in 2026.
• The last three Research & Development figures came in at $5.9 million (Q2 2026), $5.2 million (Q1 2026), and $4.5 million (Q4 2025), per Business Quant data.